Account wins from the 10/24/06 News Brief

Share this article:
Porter Novelli subsidiary FischerHealth announced a new client relationship with UltraShape North America developer of Contour I, an ultrasound system for non-invasive body contouring sold outside the US and awaiting marketing approval by the FDA. FischerHealth will represent the client in the US and Canada in conjunction with its parent company, Porter Novelli, which is spearheading UltraShape’s global campaigns.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Payment database confounds doctors

ProPublica reports that doctors are struggling with a time-intensive registration process and are getting an error message that CMS says is not an error message.

Gilead's idelalisib hat trick

The FDA greenlighted the drug for three cancers.

Shire expands rare disease reach

A $225-million deal with US biotech ArmaGen gives Shire worldwide commercialization rights to an experimental enzyme replacement therapy.